1. Home
  2. MKSI vs ROIV Comparison

MKSI vs ROIV Comparison

Compare MKSI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MKS Instruments Inc.

MKSI

MKS Instruments Inc.

HOLD

Current Price

$162.86

Market Cap

11.0B

Sector

Industrials

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

BUY

Current Price

$21.66

Market Cap

14.1B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
MKSI
ROIV
Founded
1961
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
14.1B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
MKSI
ROIV
Price
$162.86
$21.66
Analyst Decision
Buy
Strong Buy
Analyst Count
10
8
Target Price
$154.60
$24.31
AVG Volume (30 Days)
857.4K
8.2M
Earning Date
02-11-2026
02-09-2026
Dividend Yield
0.54%
N/A
EPS Growth
820.97
N/A
EPS
4.12
N/A
Revenue
$3,832,000,000.00
$20,329,000.00
Revenue This Year
$10.71
N/A
Revenue Next Year
$7.46
$741.42
P/E Ratio
$39.88
N/A
Revenue Growth
8.13
N/A
52 Week Low
$54.84
$8.73
52 Week High
$170.37
$23.47

Technical Indicators

Market Signals
Indicator
MKSI
ROIV
Relative Strength Index (RSI) 56.76 52.70
Support Level $160.00 $21.60
Resistance Level $164.87 $22.72
Average True Range (ATR) 5.21 0.83
MACD -0.29 -0.07
Stochastic Oscillator 67.98 45.58

Price Performance

Historical Comparison
MKSI
ROIV

About MKSI MKS Instruments Inc.

MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: